12:00 AM
 | 
Sep 10, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Irribow ramosetron hydrochloride regulatory update

Astellas submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) for Irribow ramosetron hydrochloride orally disintegrating tablets...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >